Manar Al Shahrouri, MD
Pulmonary Disease · Green Bay, WINPI 1093731382
Payments from drug & device makers
What this record shows
This record is dominated by education: $51,198 of the $60,783 with a category attached, or 84.2%. Intuitive Surgical accounts for 99.0% of it on its own, with 5 other manufacturers making up the rest. 2024 is the largest year on record at $44,896, 9.5 times the $4,705 reported in 2022. Among pulmonary disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $779.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$60K
- Abiomed$287
- Actelion Pharmaceuticals US, Inc.$198
- Olympus America Inc.$56
- Grifols USA, LLC$23
- Covis Pharma GmbH$17
What the payments were for
- Travel & lodging$6,13510%
- Food & beverage$3,4506%
- Education$51,19884%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 70 | $60,202 |
| Abiomed | 3 | $287 |
| Actelion Pharmaceuticals US, Inc. | 2 | $198 |
| Olympus America Inc. | 1 | $56 |
| Grifols USA, LLC | 1 | $23 |
| Covis Pharma GmbH | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$56,451
- DAVINCI XI$3,000
- Impella$269
How this compares
$60,783 in reported general payments places this provider in the 95th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 21 | $312,234 |
| EsbrietPirfenidone | 25 | $261,309 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 99 | $79,246 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 74 | $42,896 |
| Spiriva RespimatTiotropium Bromide | 25 | $22,709 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 27 | $17,994 |
| Ambrisentan | 12 | $15,214 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $14,475 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 27 | $12,960 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 62 | $11,745 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $9,540 |
| SymbicortBudesonide/Formoterol Fumarate | 34 | $9,109 |
| Spiriva HandihalerTiotropium Bromide | 14 | $8,076 |
| Arnuity ElliptaFluticasone Furoate | 18 | $7,792 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 74 | $2,906 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Green Bay
- Prince NtiamoahGreen Bay$37K
- Musab NusratGreen Bay$12K
- Jeremy RenzGreen Bay$10K
- Fazal RaziqGreen Bay$8K
- Raul Mendoza AyalaGreen Bay$7K
- Ramya GorthiGreen Bay$6K
- Pamela SudGreen Bay$4K
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Hasnain BawaadamKenosha$686K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.